With vast commercial, technical and regulatory experience within the business, we are in an ideal position to develop, register and commercialise a wide range of products.
Synchrony has a history of developing high quality generic injectable dossiers, often with early entry patent advantage with an emphasis on EU GMP.
Speciality Pharmacutical Range
There are several innovative products in an advanced stage of development, which will further extend our patient reach. These products are either novel formulations, or, are difficult to source/manufacture generics. For reasons of confidentiality these products are not disclosed below.
We encourage you to learn more about these exciting products by Contacting us.
|Product Name||Dosage Form||Strength|
|Meropenem||Powder for solution for infusion||500mg/1g|
|Zoledronic Acid||Concentrate for infusion||4mg/5ml|
|Bortezomib||Powder for solution for infusion||3.5mg|
|Pemetrexed||Powder for solution for infusion||100mg/500mg|
|Magnesium Sulfate||Solution for infusion||10% w/v|
|Magnesium Sulfate||Solution for infusion||20% w/v|
|Labetalol||Solution for injection||5mg/ml|
|Chlorphenamine||Solution for injection||10mg/ml|
|Cyclizine||Solution for injection||50mg/ml|